Induced Pluripotent Stem Cell Derived Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Induced pluripotent stem cell (iPSC)-derived neurons are patient-specific neural cells generated by reprogramming adult somatic cells (typically fibroblasts or blood cells) back to a pluripotent state, then directing their differentiation into specific neuronal subtypes. This technology has revolutionized neurodegenerative disease research by providing human disease-relevant cellular models that capture patient-specific genetic backgrounds.
Adult somatic cells are reprogrammed using the Yamanaka factors:
- OCT4: Maintains pluripotency
- SOX2: Neural lineage priming
- KLF4: Cellular reprogramming
- c-MYC: Proliferation enhancement
Methods include integration-free episomal vectors, mRNA transfection, or small molecule approaches to avoid genomic disruption.
iPSCs are guided toward neural lineage through:
- Dual SMAD inhibition: SB431542 + LDN-193189
- Neuroectoderm specification
- Rosette formation
Directed differentiation protocols yield specific neuron types:
- Dopaminergic neurons: For Parkinson's disease models
- Motor neurons: For ALS studies
- Cortical neurons: For Alzheimer's disease research
- Forebrain inhibitory neurons: For various applications
Young neurons require extended culture (months) to achieve:
- Functional synapse formation
- Action potential generation
- Neurotransmitter release capability
- Amyloid pathology: Patient-specific neurons reveal AD-relevant amyloid-beta production
- Tau dysfunction: Direct observation of tau phosphorylation and spreading
- Drug screening: Testing candidate compounds on patient neurons
- APOE effects: Modeling APOE4 risk allele effects
- Alpha-synuclein: Modeling Lewy body pathology in patient neurons
- LRRK2 mutations: Studying the most common genetic cause of PD
- Mitochondrial dysfunction: Live imaging of mitochondrial defects
- Dopaminergic neurons: Specifically relevant to SNc vulnerability
- C9orf72 expansions: Modeling hexanucleotide repeat expansions
- TDP-43 pathology: Observing protein aggregation
- SOD1 mutations: Classic ALS genetic model
- Motor neuron degeneration: Direct study of cell death mechanisms
- tau and TDP-43 pathology: Modeling proteinopathies
- Patient-specific phenotypes: Understanding genetic subtypes
- Captures individual genetic variation
- Enables study of sporadic disease
- Personalized medicine applications
- Human neurons (not rodent)
- Developmental and disease stage specificity
- Physiological relevance
- High-throughput drug testing
- Patient-stratified screening
- Biomarker discovery
¶ Challenges and Limitations
- Variable reprogramming efficiency between patients
- Incomplete maturation compared to adult neurons
- Reprogramming artifacts and genomic instability
- High cost and labor intensity
- Juvenile state of derived neurons
- Lack of aging-associated changes
- Absence of glial interactions in monocultures
¶ Standardization
- Need for harmonized protocols
- Quality control benchmarks
- Reproducibility across lines
iPSC technology has enabled:
- Living models of human neurodegenerative diseases
- Understanding of disease mechanisms inaccessible previously
- Discovery of novel therapeutic targets
- Patient stratification for clinical trials
Induced Pluripotent Stem Cell Derived Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Induced Pluripotent Stem Cell Derived Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Takahashi K, et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts. Cell, 131(5): 861-872
- Kondo T, et al. (2018). Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. Cell Stem Cell, 22(4): 486-499
- Chatterjee P, et al. (2018). Enhanced synaptic protein and vesicle marker synaptophysin levels in glutamatergic neurons in Parkinson's disease iPSC-derived neurons. Molecular Brain, 11(1): 30
- Sareen D, et al. (2013). Targeting RNA foci in iPSC-derived motor neurons from C9orf72 ALS patients. Acta Neuropathologica Communications, 1(1): 46